10
Views
4
CrossRef citations to date
0
Altmetric
Original Article

High-Dose Cyclophosphamide, Etoposide and BCNU with Non-Cryopreserved Autologous Bone Marrow Transplantation for Poor Prognosis Malignant Lymphoma

, , &
Pages 219-222 | Received 12 May 1991, Accepted 21 Jul 1991, Published online: 01 Jul 2009

References

  • Armitage J. O., Vose J. M., Bierman P. J. Salvage therapy for patients with non-Hodgkin's lymphoma. Monogr. J. Natl. Cancer Inst 1990; 10: 39–43
  • Gribben J. G., Goldstone A. H., Linch D. C., Taghipour G., McMillan A. K., Souhami R. L., Earl H., Richards J. D. Effectiveness of high-dose combination chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphomas who are still responsive to conventional-dose therapy. J. Clin. Oncol 1989; 7: 1621–1629
  • Vose J. M., Armitage J. O., Bierman P. J. Salvage therapy for relapsed or refractory non-Hodgkin's lymphoma utilizing autologous bone marrow transplantation. Am. J. Med 1989; 87: 285–288
  • Freedman A. S., Takvorian T., Anderson K. C. Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse. J. Clin. Oncol 1990; 8: 784–791
  • Colombat P., Gorin N. C., Lemonnier M. P. The role of autologous bone marrow transplantation in 46 adult patients with non-Hodgkin's lymphomas. J. Clin. Oncol 1990; 8: 630–637
  • Petersen F. B., Appelbaum F. R., Hill R. Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle. J. Clin. Oncol 1990; 8: 638–647
  • Bonadonna G., Santoro A. Current issues in the management of advanced Hodgkin's disease. Blood Rev 1990; 4: 69, 73
  • Gribben J. G., Linch D. C., Singer C. R. J., McMillan A. K., Jarret M., Goldstone A. H. Successful treatment of refractory Hodgkin's disease by high-dose combination chemotherapy and autologous bone marrow transplantation. Blood 1989; 73: 340–344
  • Jones R. J., Piantadosi S., Mann R. E. High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's disease. J. Clin. Oncol 1990; 8: 537–537
  • Spinolo J. A., Jagannath S., Dicke K. A. High-dose combination chemotherapy with cyclophosphamide, carmustine, etoposide, and autologous bone marrow transplantation in 60 patients with relapsed Hodgkin's disease: the M.D. Anderson experience. Recent Results Cancer Res 1989; 117: 233–238
  • Thomas E. D., Storb R. Technique for human marrow grafting. Blood 1970; 36: 507–515
  • Buckner C. D., Appelbaum F. R., Thomas E. D. Bone marrow and fetal liver, A. M. Karow, Jr., D. E. Pegg. Organ preservation for transplantation Dekker, New York, NY 1981; 355–375
  • Mangalik A., Robinson W. A., Drebing C., Hartmann D., Joshi J. H. Liquid storage of bone marrow. Exp. Hematol 1979; 7: 76–94, Suppl. 5
  • Lasky L. C., McCullough J., Zanijani E. D. Liquid storage of unseparated human bone marrow. Transfusion 1986; 26: 331–334
  • Robinson W. A., Hartmann D., Mangalik A., Morton N., Joshi J. H. Autologous non-frozen bone marrow transplantation after intensive chemotherapy: a pilot study. Acta Haemat 1981; 66: 145–153
  • Thomas M. R., Robinson W. A., Glode L. M., Dantas M. D., Koeppler H., Morton N., Sutherlands I. Treatment of advanced malignant melanoma with high-dose chemotherapy and autologous bone marrow transplantation. Am. J. Clin. Oncology 1982; 5: 611–621
  • Pritchard J., McElwain T. J., Graham-Pole J. High-dose melphalan with autologous bone marrow for treatment of advanced neuroblastoma. Br. J. Cancer 1981; 45: 86–94
  • Koeppler H., Pflueger K. H., Wolf M., Weide R., Havemann K. High-dose chemotherapy with non-cryopreserved autologous bone marrow transplantation for acute leukemia in first complete remission. Haematol. Blood Transfusion 1990; 33: 699–701
  • Carella A. M., Santini G., Santoro A. Massive chemotherapy with non-frozen autologous bone marrow transplantation in 13 cases of refractory Hodgkin's disease. Eur. J. Cancer Clin. Oncol 1986; 21: 607–613
  • Russell J. A., Selby P. J., Ruether B. A. Treatment of advanced Hodgkin's disease with high-dose melphalan and autologous bone marrow transplantation. Bone Marrow Transplantation 1989; 4: 425–429
  • Carey P. J., Taylor P., Jackson G. ABMT for poor prognosis NHL in first remission—lack of toxicity using melphalon +/- TBI conditioning without marrow cryopreservation or purging. Br. J. Haematol 1990; 74: 51, Suppl. 1
  • Kaplan E. L., Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc 1958; 53: 457–481
  • Dunphy F. k., Spitzer G., Buzdar A. U. Treatment of estrogen receptor-negative or hormonally refractory breast cancer with double high-dose chemotherapy intensification and bone marrow support. J. Clin. Oncol 1990; 8: 1207–1216
  • Wheeler C., Antin J. H., Churchill W. H. Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: a dose-finding study. J. Clin. Oncol 1990; 8: 648–656

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.